ArticleBritish journal of haematology2018

Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.

Mitchell Cairo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.